| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2007.10.053 |
| P698 | PubMed publication ID | 18053620 |
| P2093 | author name string | Janne Aittoniemi | |
| Marjatta Sinisalo | |||
| Juhani Vilpo | |||
| Maija Itälä | |||
| Merja Väkeväinen | |||
| Jyrki Taurio | |||
| P2860 | cites work | Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response | Q78660870 |
| B-cell chronic lymphocytic leukemia: a bird of a different feather | Q28142747 | ||
| Diagnostic criteria for monoclonal B-cell lymphocytosis | Q33988895 | ||
| Infection and immunity in chronic lymphocytic leukemia. | Q34065579 | ||
| Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants | Q34205630 | ||
| Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomata | Q35250081 | ||
| Infections and serum IgG levels in patients with chronic lymphocytic leukemia | Q36379517 | ||
| Immunoregulatory cell dysfunction in chronic B-cell leukemias | Q37997489 | ||
| Immunobiology of malignant B cells and immunoregulatory cells in B-chronic lymphocytic leukemia. | Q39467411 | ||
| Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay | Q39507980 | ||
| Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment | Q40682805 | ||
| Vaccination against infections in chronic lymphocytic leukemia | Q44455483 | ||
| Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children | Q52051185 | ||
| Conjugate vaccines. | Q55033615 | ||
| Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine | Q57384998 | ||
| Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era | Q64129632 | ||
| Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial | Q69924073 | ||
| Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia | Q71234863 | ||
| Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults | Q73294615 | ||
| Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia | Q73414332 | ||
| Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia | Q74263359 | ||
| P433 | issue | 1 | |
| P921 | main subject | pneumococcal vaccine | Q14538008 |
| P304 | page(s) | 82-87 | |
| P577 | publication date | 2007-11-12 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia | |
| P478 | volume | 26 |
| Q38220556 | A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older |
| Q47552836 | Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies |
| Q34704085 | Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report. |
| Q38190015 | Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin? |
| Q50116286 | Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia |
| Q33412266 | Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths |
| Q80719180 | Efficacy of pneumococcal vaccination in chronic lymphocytic leukemia: should we rely on surrogate markers? |
| Q81366101 | Efficacy of pneumococcal vaccination on chronic lymphocytic leukemia: should we rely on surrogate markers? |
| Q63762070 | Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study |
| Q60699516 | European consensus proposal for immunoglobulin therapies |
| Q61833685 | Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia |
| Q40254202 | Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression. |
| Q38025781 | Immunization in Special Populations |
| Q37881239 | Immunization in the adult immunocompromised host |
| Q50064384 | Immunogenicity And Persistence Of A Prime-Boost Re-Vaccination Strategy For Pneumococcal Vaccines In Patients With Rheumatoid Arthritis |
| Q91771793 | Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial |
| Q46048464 | Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study |
| Q28079486 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety |
| Q33419638 | Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe |
| Q33780253 | Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway |
| Q36328087 | Mixed Streptococcus pneumoniae and Streptococcus pyogenes meningitis in an immunocompromised adult patient: a case report |
| Q88632436 | Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group |
| Q36388960 | Practical review of immunizations in adult patients with cancer |
| Q38893343 | Secondary immunodeficiency in lymphoproliferative malignancies. |
| Q35860550 | State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia |
| Q38050852 | Vaccination of immunocompromised patients |
| Q91465250 | Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
| Q37708365 | Vaccinations in children with cancer |
Search more.